Challenged one year after vaccination, Bovi-Shield GOLD FP
®:
- Blocked the BVD virus from heifers and their fetuses.2,3
- Prevented BVD Types 1 & 2 persistently infected (PI) calves.2,3
- Delivered exceptional protection from IBR abortion for heifers and their fetuses.4
With a unique BVD Type 2 strain, it has the strength to protect.
- Exceptional year-round fetal protection.*
- Exceptional respiratory protection.
- Aids in the prevention of BVD Type 2 testicular infection.
Bovi-Shield GOLD delivers demonstrated respiratory protection. In tests against an extremely severe BVD Type 2 disease challenge model,
5
vaccinates showed:
- 99 percent fewer viremic days.
- At least 95 percent less fever and sick days.
- No death loss compared to 70 percent mortality in controls.
- Granted “aids in prevention” claim for respiratory disease protection by the USDA.
* LABEL INDICATIONS: The Bovi-Shield GOLD line and PregGuard® GOLD FP® 10 may be administered to pregnant cattle provided they were vaccinated, according to label directions, with any Bovi-Shield® FP or PregGuard® FP vaccine prior to breeding initially and within 12 months thereafter. The Bovi-Shield GOLD line of products may be administered to calves nursing pregnant cows provided their dams were vaccinated within the last 12 months as described above. Consistent with good vaccination practices, it is recommended that heifers receive at least 2 doses, with the second dose administered approximately 30 days prebreeding.
1 The National Survey of the U.S. Animal Health Market, MDI 2005
2 Data on file, Study 3131R-60-03-284,
Pfizer Inc
3 Data on file, Study 3131R-60-03-285, Pfizer Inc
4 Data on file, Study 3131R-60-03-283, Pfizer Inc
5 Data on file, Study 3131R-60-02-258, Pfizer Inc
Bovi-Shield GOLD and FP are registered trademarks and Gain everything. Sacrifice nothing. is a trademark of Pfizer Inc.